TY - JOUR
T1 - How to deal with vaccine hesitancy?
AU - the SAGE Working Group on Vaccine Hesitancy
AU - Eskola, Juhani
AU - Duclos, Philippe
AU - Schuster, Melanie
AU - MacDonald, Noni E.
AU - Liang, Xiaofeng
AU - Chaudhuri, Mohuya
AU - Dube, Evé
AU - Gellin, Bruce
AU - Goldstein, Susan
AU - Larson, Heidi
AU - Manzo, Mahamane Laouali
AU - Reingold, Arthur
AU - Tshering, Kinzang
AU - Zhou, Yuqing
AU - Guirguis, Sherine
AU - Hickler, Ben
N1 - Publisher Copyright:
© 2015.
PY - 2015/8/14
Y1 - 2015/8/14
N2 - Based on the concerns about vaccine hesitancy and its impact on vaccine uptake rates and the performance of national immunization programmes, the Strategic Advisory Group of Experts (SAGE) on Immunization Working Group on Vaccine Hesitancy [1], carried out a review, and proposed a set of recommendations directed to the public health community, to WHO and its partners, and to the World Health Organization (WHO) member states. The final recommendations issued by SAGE in October 2014 fall into three categories: (1) those focused on the need to increase the understanding of vaccine hesitancy, its determinants and the rapidly changing challenges it entails; (2) those focused on dealing with the structures and organizational capacity to decrease hesitancy and increase acceptance of vaccines at the global, national and local levels; (3) and those focused on the sharing of lessons learnt and effective practices from various countries and settings as well as the development, validation and implementation of new tools to address hesitancy.
AB - Based on the concerns about vaccine hesitancy and its impact on vaccine uptake rates and the performance of national immunization programmes, the Strategic Advisory Group of Experts (SAGE) on Immunization Working Group on Vaccine Hesitancy [1], carried out a review, and proposed a set of recommendations directed to the public health community, to WHO and its partners, and to the World Health Organization (WHO) member states. The final recommendations issued by SAGE in October 2014 fall into three categories: (1) those focused on the need to increase the understanding of vaccine hesitancy, its determinants and the rapidly changing challenges it entails; (2) those focused on dealing with the structures and organizational capacity to decrease hesitancy and increase acceptance of vaccines at the global, national and local levels; (3) and those focused on the sharing of lessons learnt and effective practices from various countries and settings as well as the development, validation and implementation of new tools to address hesitancy.
UR - http://www.scopus.com/inward/record.url?scp=84941316389&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84941316389&partnerID=8YFLogxK
U2 - 10.1016/j.vaccine.2015.04.043
DO - 10.1016/j.vaccine.2015.04.043
M3 - Article
C2 - 25896378
AN - SCOPUS:84941316389
SN - 0264-410X
VL - 33
SP - 4215
EP - 4217
JO - Vaccine
JF - Vaccine
IS - 34
ER -